Medium materiality6/10
Adaptive Biotechnologies price target raised to $27 from $22 at Morgan Stanley
Why it may matterVerify against the original reporting
target_up
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises ADPT target to $27; current price $25.66.
- Target: $27; Price: $25.66; Firm: Morgan Stanley
Key facts
- 01
Target: $27
- 02
Posted price: $25.66
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.